Kendall M J, Spannuth F, Walt R P, Gibson G J, Hale K A, Braithwaite R, Langman M J
Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham.
Br J Clin Pharmacol. 1994 Apr;37(4):371-4. doi: 10.1111/j.1365-2125.1994.tb04291.x.
The possibility of a pharmacokinetic interaction between H2-receptor antagonists and alcohol consumed at lunchtime, was investigated in 24 healthy non-alcoholic male subjects, each receiving ranitidine 150 mg four times daily, cimetidine 400 mg four times daily, famotidine 20 mg four times daily and placebo in an open, four-way cross-over study. The subjects consumed 50 g alcohol after a standard lunch on the eighth day of dosing with study medication. Blood samples taken during the 6 h after alcohol consumption were analysed for alcohol concentrations by gas liquid chromatography using head space analysis. None of the H2-receptor antagonists had any statistically significant effects on any of the pharmacokinetic parameters for alcohol. Mean Cmax (95% CI) results for ranitidine were 547 (516, 580), cimetidine 531 (501, 563), famotidine 563 (530, 598) and placebo 529 (499, 561) mg l-1.
在一项开放性、四交叉研究中,对24名健康的非酒精性男性受试者进行了研究,以探讨午餐时服用的H2受体拮抗剂与酒精之间发生药代动力学相互作用的可能性。每位受试者每日四次服用雷尼替丁150毫克、西咪替丁400毫克、法莫替丁20毫克以及安慰剂。在服用研究药物的第八天,受试者在标准午餐后饮用50克酒精。饮酒后6小时内采集的血样通过顶空分析气相色谱法分析酒精浓度。H2受体拮抗剂对酒精的任何药代动力学参数均无统计学上的显著影响。雷尼替丁的平均Cmax(95%CI)结果为547(516,580)、西咪替丁为531(501,563)、法莫替丁为563(530,598),安慰剂为529(499,561)毫克/升。